Screener
Actinium Pharmaceuticals ATNM Q1 2025 Annual earnings
Reported May 9, 2025 · Before market open
EPS-$0.51Miss by $0.25
EPS estimate-$0.26
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$1.2M
EPS estimate-$0.25
Versus estimates
Diluted EPS
FAQ
- When did Actinium Pharmaceuticals report Q1 2025 earnings?
- Actinium Pharmaceuticals (ATNM) reported Q1 2025 earnings on May 9, 2025 before market open.
- What were Actinium Pharmaceuticals's Q1 2025 revenue and EPS?
- Actinium Pharmaceuticals reported eps of $-0.51 for Q1 2025.
- Did Actinium Pharmaceuticals beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.26 by $0.25.
- How did Actinium Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 64.5% from $-0.31.
- Where can I find Actinium Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-041582) and the 10-K periodic report (0001213900-25-026371) directly on SEC EDGAR. The filing index links above go to sec.gov.
